KathleenM.SchmelerMD

Gynecologic Oncology

Associate Professor in the Department of Gynecologic Oncology and Reproductive Medicine - University of Texas MD Anderson Cancer Center.

Join to view full profile

Dr. Schmeler is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Schmeler's full profile

Already have an account?

Office
1515 Holcombe Blvd
Houston, TX 77030
Phone+1 713-792-6161

Education & Training

University of Texas M D Anderson Cancer CenterFellowship, Gynecologic Oncology, 2004 - 2007
Women and Infants Hospital of Rhode Island/Brown UniversityResidency, Obstetrics and Gynecology, 2000 - 2004
Drexel University College of MedicineClass of 2000

Certifications & Licensure

FL State Medical License 2021 - Present
TX State Medical License 2005 - 2026
WA State Medical License 2023 - 2026
AL State Medical License 2023 - 2025
AZ State Medical License 2023 - 2025
GA State Medical License 2023 - 2025
LA State Medical License 2023 - 2025
MS State Medical License 2023 - 2025
OK State Medical License 2020 - 2025
TN State Medical License 2023 - 2025
American Board of Obstetrics and Gynecology Obstetrics & Gynecology
American Board of Obstetrics and Gynecology Gynecologic Oncology
Join now to see all

Awards, Honors, & Recognition

Fellow (FACOG) American Congress of Obstetricians and Gynecologists

Clinical Trials

Laparoscopic Approach to Cervical Cancer Start of enrollment: 2008 Jan 01
Completed
Not Applicable
Pelvic Fractures and Radiation Therapy for Cervical Cancer Start of enrollment: 2008 Nov 05
Active, not recruiting
Conservative Surgery in Treating Patients With Low-Risk Stage IA2 or IB1 Cervical Cancer Start of enrollment: 2009 Aug 25
Active, not recruiting
Not Applicable
Biospecimen Collection and Testing for the Prevalence of Anal Dysplasia and Anal Cancer in Patients With Cervical, Vaginal and Vulvar Dysplasia and Cancer Start of enrollment: 2014 Oct 27
Active, not recruiting
Not Applicable
Use of High-Resolution Microendoscopy (HRME) in Patients With Adenocarcinoma In-Situ (AIS) of the Cervix Start of enrollment: 2015 Oct 02
Completed
Not Applicable
Low-Cost Imaging for Cervical Cancer Prevention in the Texas Lower Rio Grande Valley Start of enrollment: 2016 Oct 25
Active, not recruiting
Early Phase 1
Novel Point-of-Care Diagnostic Test for SARS-CoV-2 (COVID-19) Start of enrollment: 2020 Apr 09
Active, not recruiting
Not Applicable
PEER Trial: Part 2 Rice Technologies Start of enrollment: 2021 Mar 24
Recruiting
Not Applicable
Roles: Principal Investigator, Contact
Evaluating Innovative Technologies and Approaches to Addressing Cervical Cancer in Gaza and Maputo Cidade Provinces in Mozambique Start of enrollment: 2020 Dec 22
Recruiting
Phase 2
Roles: Contact, Principal Investigator
Evaluation of a Novel Point-of-Care Diagnostic Test for Human Papillomavirus (HPV) Start of enrollment: 2024 Nov 29
Not yet recruiting
Roles: Principal Investigator, Contact
Join now to see all

Publications & Presentations

PubMed

Pembrolizumab plus chemotherapy in frontline treatment of advanced ovarian cancer: Clinical and translational results from a phase 2 trial.
Jeffrey A How, Minghao Dang, Sanghoon Lee, Bryan Fellman, Shannon N Westin
Med. 2025-01-10
Scaling cervical cancer screening in Mozambique: analysis of loop electrosurgical excision procedure (LEEP) specimens.
Sydney Chambule, Ricardina Rangeiro, Samantha Batman, Eva Lathrop, Nafissa Osman
International Journal of Gynecological Cancer. 2024-11-04
1 citations
Metronidazole and cefazolin vs cefazolin alone for surgical site infection prophylaxis in gynecologic surgery at a comprehensive cancer center.
Anne Knisely, Maria D Iniesta, Claire A Marten, Gary Chisholm, Kathleen M Schmeler
American Journal of Obstetrics and Gynecology. 2024-09-01

Journal Articles

Prospective Phase II Trial of Levonorgestrel Intrauterine Device: Non-Surgical Approach for Complex Atypical Hyperplasia and Early Endometrial Cancer
Shannon N Westin, Lois M Ramondetta, Kathleen M Schmeler, Pamela T Soliman, Nicole D Fleming, Jennifer K Burzawa, Alpa M Nick, Andrea M Milbourne, Diane C Bodurka, Rob..., American Journal of Obstetrics and Gynecology

Other

Endometrial and ovarian cancer screening and prevention in women with Lynch syndrome (hereditary nonpolyposis colorectal cancer)
Schmeler KM, Lu KH
http://www.uptodate.com/contents/endometrial-and-ovarian-cancer-screening-and-prevention-in-women-wi
UpToDate, Wolters Kluwer Health - 2012-11-12

Authored Content

Prospective Phase II Trial of Levonorgestrel Intrauterine Device: Non-Surgical Approach for Complex Atypical Hyperplasia and Early Endometrial CancerAugust 2020
Prospective Phase II Trial of Levonorgestrel Intrauterine Device: Non-Surgical Approach for Complex Atypical Hyperplasia and Early Endometrial CancerAugust 2020

Press Mentions

Physicians Applaud New HPV Testing Guidance, Support Self-CollectionDecember 23rd, 2024
How MD Anderson Uses Teleconsulting to Tackle Care GapsNovember 20th, 2024
HPV Vaccine: Some Studies Say One and Done Might Be BetterMay 22nd, 2023
Join now to see all